F. Pellett

发表

High resolution mapping in the major histocompatibility complex region identifies multiple independent novel loci for psoriatic arthritis

A. Paterson, C. Greenwood, D. Gladman, 2011, Annals of the rheumatic diseases.

Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity

D. Gladman, V. Chandran, C. Rosen, 2012, Annals of the rheumatic diseases.

Further Evidence Supporting a Parent‐of‐Origin Effect in Psoriatic Disease

D. Gladman, P. Rahman, A. Petronis, 2015, Arthritis care & research.

Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease

D. Gladman, E. Diamandis, M. Steinhoff, 2012, Clinical chemistry and laboratory medicine.

Cutting Edge: Susceptibility to Psoriatic Arthritis: Influence of Activating Killer Ig-Like Receptor Genes in the Absence of Specific HLA-C Alleles1

Michael J. Wilson, M. Carrington, J. Trowsdale, 2002, The Journal of Immunology.

IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients

D. Gladman, P. Rahman, V. Chandran, 2011, Annals of the rheumatic diseases.

Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis.

S. Bull, D. Gladman, V. Chandran, 2014, Rheumatology.

Association of variably expressed KIR3dl1 alleles with psoriatic disease

D. Gladman, V. Chandran, A. Thavaneswaran, 2017, Clinical Rheumatology.

HLA-C Alleles Genes in the Absence of Specific Receptor Killer Ig-Like Arthritis : Influence of Activating Cutting Edge : Susceptibility to Psoriatic

Michael J. Wilson, M. Carrington, J. Trowsdale, 2002 .

Fine Mapping Major Histocompatibility Complex Associations in Psoriasis and Its Clinical Subtypes

Vinod Chandran, Buhm Han, Proton Rahman, 2014, American journal of human genetics.

Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity

Matti Pirinen, Christian Gieger, Peter Donnelly, 2012 .

Soluble Biomarkers Associated with Response to Treatment with Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis

D. Gladman, V. Chandran, R. Cook, 2013, The Journal of Rheumatology.

Human leukocyte antigen alleles and susceptibility to psoriatic arthritis.

S. Bull, D. Gladman, P. Rahman, 2013, Human immunology.

Minimal Disease Activity and Anti–Tumor Necrosis Factor Therapy in Psoriatic Arthritis

D. Gladman, V. Chandran, R. Cook, 2015, Arthritis care & research.

Clinical and Demographic Characteristics of Erosion-free and Erosion-present Status in Psoriatic Arthritis in a Cohort Study

D. Gladman, V. Chandran, R. Cook, 2016, The Journal of Rheumatology.

Differential human leucocyte allele association between psoriasis and psoriatic arthritis: a family-based association study

S. Bull, D. Gladman, V. Chandran, 2012, Annals of the rheumatic diseases.

Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis.

Vinod Chandran, Richard J Cook, D. Gladman, 2010, Rheumatology.

Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex

M. Carrington, J. Trowsdale, D. Middleton, 2009, Human molecular genetics.

HLA associations in patients with pemphigus vulgaris: A Canadian perspective: 976

D. Gladman, S. Kalia, R. Mydlarski, 2015 .

HLA is a candidate region for psoriatic arthritis. evidence for excessive HLA sharing in sibling pairs.

D. Gladman, P. Rahman, V. Farewell, 2003, Human immunology.

UGT2B17 copy number gain in a large ankylosing spondylitis multiplex family

D. Gladman, P. Rahman, M. Uddin, 2013, BMC Genetics.

HLA markers for susceptibility and expression in scleroderma.

D. Gladman, F. Siannis, V. Farewell, 2005, The Journal of rheumatology.

Folate Pathway Enzyme Gene Polymorphisms and the Efficacy and Toxicity of Methotrexate in Psoriatic Arthritis

D. Gladman, F. Siannis, P. Rahman, 2010, The Journal of Rheumatology.

of Methotrexate in Psoriatic Arthritis Folate Pathway Enzyme Gene Polymorphisms and the Efficacy and Toxicity

D. Gladman, F. Siannis, P. Rahman, 2010 .

TNFα polymorphisms and risk of psoriatic arthritis

D. Gladman, F. Siannis, C. Butt, 2005 .

Gene expression differences between psoriasis patients with and without inflammatory arthritis.

D. Gladman, V. Chandran, C. Virtanen, 2015, The Journal of investigative dermatology.

Familial aggregation of psoriatic arthritis

D. Gladman, P. Rahman, V. Chandran, 2008, Annals of the rheumatic diseases.

KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma.

D. Gladman, M. Urowitz, F. Siannis, 2007, Tissue Antigens.

CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis.

D. Gladman, F. Siannis, P. Rahman, 2003, American journal of human genetics.

Association of killer cell immunoglobulin–like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus

D. Gladman, M. Urowitz, M. Urowitz, 2008, Lupus.

Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease.

D. Gladman, V. Farewell, V. Chandran, 2011, Tissue antigens.